This page shows the latest Pfizer UK news and features for those working in and with pharma, biotech and healthcare.
Dr Gillian Ellsbury, medical director, vaccines and antivirals, at Pfizer UK, said the latest approval of the vaccine “represents significant progress towards reducing the impact of respiratory disease caused by the ... virus”. “The vaccine has the
The IMC partners are Antibiotic Research UK, the Association of British HealthTech Industries (ABHI), the Association of the British Pharmaceutical Industry (ABPI), BD, bioMérieux, the British In Vitro Diagnostics Association (BIVDA), ... the British
Pfizer hopes the newly developed vaccine will offer better and more reinforced protection against the Omicron variant. ... Current data from the UK has shown that both Pfizer and Moderna’s vaccines are only around 10% effective at preventing
A single shot of Pfizer’s COVID-19 vaccine will be offered to 30 million people in the UK including those 50 or over and frontline health and social care workers. ... protection. The JCVI advice is based on trials that have been carried out in the UK,
The pricing of COVID-19 vaccines is once again in the headlines after the UK ordered 32 million doses of Pfizer/BioNTech’s Comirnaty for £22 a shot, up from £18 ... Pfizer also expects revenue for Comirnaty to top out at $33.5bn by the end of 2021.
AbbVie, Biogen and Pfizer have formed a collaboration in a bid to launch the world’s largest browsable resource for genetic exome sequencing analysis. ... The health resource’s whole exome sequencing data was generated as part of the UK Biobank Exome
More from news
Approximately 2 fully matching, plus 160 partially matching documents found.
Previously the head of Pfizer’s UK and Ireland vaccines business unit, Darius joined Moderna as its first UK employee in July 2021. ... with the express mission of introducing a COVID-19 vaccine to the UK.
communications. She spent the last decade working as a director of communications for Pfizer, Inc., in New York, the UK and Paris.
Jack Brownrigg, Medical Affairs, Rare Disease, Pfizer UK, told us clinical trials with fewer potential participants required more nuanced trial designs. ... Patient-centricity is also core to Pfizer’s rare disease recruitment strategy, said Brownrigg.
The hearing was more or less unprecedented in terms of a pharma company’s CEO being called on to explain its tactics before UK Parliament – the questioning of Pfizer’s ... These included questions to Jeff Leiden about his salary, the company’s
Pfizer’s UK managing director and newly appointed ABPI President talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe. ... 10.8% of GDP is spent on healthcare in the Netherlands versus 9.8% in the UK.
More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.
Shafie's previous experience includes roles at the ABPI and Pfizer UK. ... Shafie’s career experience includes time spent as head of government affairs at the ABPI and corporate public affairs lead for Pfizer UK.
Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area ... Prior to his time with Pfizer, Maine was
director. Finke brings 15 years industry experience from the likes of Shire and Wyeth (now part of Pfizer) to the Southampton, UK-based agency, having previously worked on market access challenges
Airey (pictured right) becomes venture developer at the biotech, bringing 28 years of healthcare operating experience at firms including Baxter and Pfizer across the UK, Europe and India.
He replaces Jonathan Emms, who is stepping down as president as he is leaving his role as head of Pfizer's UK business to a new role with the company in ... Kearney held UK and international roles at GlaxoSmithKline and international roles at Pfizer,
More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.
doi:10.1136/bmj.n129. 24. Dean G, Reuters. The UK approved Pfizer’s vaccine too quickly and without the proper checks, EU politicians have warned. ... Business
Wilmington Healthcare, which provides data, insight and intelligence for pharma and medtech companies, has appointed Pfizer’s former UK Digital Marketing Manager, Mikko Figura, as Head of Digital. ... Prior to that, he was UK Digital Marketing Manager
Health Products Regulatory Agency’s speedy approval of the Pfizer-BioNTech COVID-19 vaccine in the UK. ... A good example is a recent incident in the UK that made headline news, where two NHS workers who were among the first to receive the
21Grams, Almirall, Alnylam, Amicus Therapeutics, AstraZeneca, Biogen, Boldscience, Caudex, Clinical Thinking, Convatec, CSL Behring, EMD Serono, GSK, Havas Lynx Group, In Vivo Academy, Ipsen, Janssen, Lupus UK, Merck, Novartis, Philips, Pfizer,
Cannes or Canned? brought together UK and internationally based senior communicators from seven pharmaceutical companies. ... Lilianna Husseini, Director Communications, Oncology, Pfizer Global. Heidi LaPensée, Brand Lead, CNS, Sanofi UK.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
No results were found
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...